AbbVie Inc. (BVMF:ABBV34)
Brazil flag Brazil · Delayed Price · Currency is BRL
71.01
-3.07 (-4.14%)
At close: Feb 5, 2026

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of BRL 2.06 trillion. The enterprise value is 2.39 trillion.

Market Cap2.06T
Enterprise Value 2.39T

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date Feb 4, 2026
Ex-Dividend Date Jan 15, 2026

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) +0.11%
Owned by Insiders (%) 0.06%
Owned by Institutions (%) 73.78%
Float 1.76B

Valuation Ratios

The trailing PE ratio is 88.55 and the forward PE ratio is 15.29.

PE Ratio 88.55
Forward PE 15.29
PS Ratio 6.12
PB Ratio -143.98
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 102.72
EV / Sales 7.49
EV / EBITDA 15.57
EV / EBIT 21.59
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA 2.34
Debt / FCF n/a
Interest Coverage 8.08

Financial Efficiency

Return on equity (ROE) is 1,106.67% and return on invested capital (ROIC) is 22.47%.

Return on Equity (ROE) 1,106.67%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 22.47%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 5.52%
Revenue Per Employee 6.12M
Profits Per Employee 423,215
Employee Count55,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, AbbVie has paid 13.02 billion in taxes.

Income Tax 13.02B
Effective Tax Rate 35.83%

Stock Price Statistics

The stock price has increased by +1.69% in the last 52 weeks. The beta is 0.33, so AbbVie's price volatility has been lower than the market average.

Beta (5Y) 0.33
52-Week Price Change +1.69%
50-Day Moving Average 75.18
200-Day Moving Average 71.21
Relative Strength Index (RSI) 45.14
Average Volume (20 Days) 1,699

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.43

Income Statement

In the last 12 months, AbbVie had revenue of BRL 336.87 billion and earned 23.28 billion in profits. Earnings per share was 13.00.

Revenue336.87B
Gross Profit 241.35B
Operating Income 116.85B
Pretax Income 36.34B
Net Income 23.28B
EBITDA 162.03B
EBIT 116.85B
Earnings Per Share (EPS) 13.00
Full Income Statement

Balance Sheet

The company has 31.24 billion in cash and 379.22 billion in debt, with a net cash position of -347.98 billion.

Cash & Cash Equivalents 31.24B
Total Debt 379.22B
Net Cash -347.98B
Net Cash Per Share n/a
Equity (Book Value) -14.32B
Book Value Per Share -8.23
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 71.64%, with operating and profit margins of 34.69% and 6.91%.

Gross Margin 71.64%
Operating Margin 34.69%
Pretax Margin 10.79%
Profit Margin 6.91%
EBITDA Margin 48.10%
EBIT Margin 34.69%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 1.54, which amounts to a dividend yield of 2.17%.

Dividend Per Share 1.54
Dividend Yield 2.17%
Dividend Growth (YoY) 4.89%
Years of Dividend Growth 6
Payout Ratio n/a
Buyback Yield -0.23%
Shareholder Yield 1.94%
Earnings Yield 1.13%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 16.

Last Split Date Nov 21, 2022
Split Type Forward
Split Ratio 16

Scores

Altman Z-Score n/a
Piotroski F-Score 2